Premium
Letter: Helicobacter pylori in proton pump inhibitor‐associated biliary disease
Author(s) -
Papaefthymiou Apostolis,
Doulberis Michael,
Polyzos Stergios A.,
Katsinelos Panagiotis,
Liatsos Christos,
Koffas Apostolos,
Kazakos Evangelos,
Deretzi Georgia,
Srivastava David S.,
Kountouras Jannis
Publication year - 2020
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15608
Subject(s) - helicobacter pylori , medicine , proton pump inhibitor , gastroenterology , biliary disease , helicobacter infections
R E FE R E N C E S 1. McPherson SJ, Hammond CJ. Letter: the Shock Index and predicting outcomes in patients with upper gastrointestinal bleeding. Aliment Pharmacol Ther. 2020;51:311-312. 2. Saffouri E, Blackwell C, Laursen SB, et al. The Shock Index is not accurate at predicting outcomes in patients with upper gastrointestinal bleeding. Aliment Pharmacol Ther. 2020;51:253-260. 3. Hearnshaw SA, Logan RFA, Lowe D, Travis SPL, Murphy MF, Palmer KR. Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit. Gut. 2010;59:1022-1029. 4. Laursen SB, Laine L, Dalton H, et al. The International Bleeding Risk Score: a new risk score that can accurately predict mortality in patients with upper GI bleeding. Gastroenterology. 2017;152(Suppl 1):S149-S150. 5. Laursen SB, Oakland K, Laine L, et al. External validation of the international bleeding risk score in both upper and lower GI bleeding: an international multicentre study. UEGJ. 2018;6(8S):A126-127.